期刊文献+

启动子区5′CpG岛去甲基化对人结肠癌细胞生物学表型的影响 被引量:2

Effects of promoter region 5′CpG island demethylation on biological phenotype in human colorectal cancer cells
下载PDF
导出
摘要 目的:探讨DNA启动子区5′CpG岛甲基化状态与人结肠癌RKO细胞增殖凋亡等生物学特征的关系。方法:应用特异性DNA甲基转移酶(DNMTs)抑制剂-5-氮-2′-脱氧胞苷(5-Aza-2′-deoxycytidine,5-Aza-CdR)处理肠癌RKO细胞72h,甲基化特异性PCR(methylation-specificPCR,MSP)及DNA测序法分析p16/CDKN2基因CpG岛甲基化状态;MTT、FCM、荧光染色及透射电镜检测启动子区去甲基化后细胞生长、形态和细胞周期凋亡的影响。结果:DNMTs抑制剂能较好地逆转启动子区胞嘧啶甲基化状态;CpG岛去甲基化后能明显地抑制肠癌细胞的生长,增加细胞群体倍增时间(P<0.01),诱导肠癌细胞凋亡,影响肠癌细胞周期分布,并具有良好的量效依赖关系。结论:通过逆转CpG岛高甲基化能有效地抑制肠癌细胞增殖,为临床治疗大肠癌提供新的作用靶点。 AIM: To explore the relationship between methylation status of promoter region 5′CpG island and the biological phenotype in human colorectal cancer RKO cell lines. METHODS: RKO cells were treated with selective DNA methyltransferase (DNMTs) inhibitor, 5-Aza-2′-deoxycytidine (5-Aza-CdR), for 72 h. Methylation-specific PCR (MSP), T-A clone and DNA sequence analysis were used to detect 5′CpG island methylation status of p16/CDKN2 tumor suppresor gene. Cell growth, cell cycle arrest and apoptosis were analyzed by MTT, flow cytometry (FCM), fluorescent dye staining and transmission electron microscope. RESULTS: DNMTs inhibitor (5-Aza-CdR) effectively reversed the hypermethylation status of 5′CpG island. The effects of 5-Aza-CdR on cell growth inhibition (P<0.01), apoptosis and cell cycle arrest were observed in a dose-dependent manner. CONCLUSION: Selective DNMTs inhibitor inhibits cell growth by 5′CpG island demethylation, and this may be a potential new therapeutic target for colorectal cancer.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2005年第6期1111-1116,共6页 Chinese Journal of Pathophysiology
基金 国家(973)重点基础研究发展归划项目(No.G1998051200) 浙江省科技计划项目(No.011110541)
关键词 甲基化 结直肠肿瘤 细胞凋亡 细胞周期 脱氧胞苷 Methylation Colorectal neoplasms Apoptosis Cell cycle Deoxycytidine
  • 相关文献

参考文献14

  • 1Momparler RL, Bovenzi V. DNA Methylation and cancer[J]. J Cell Physiol, 2000, 183(2): 145-154.
  • 2Bird A. DNA methylation de novo[J]. Science, 1999, 286(5448): 2287-2288.
  • 3Esteller M, Corn PG, Baylin SB, et al. A gene hypermethylation profile of human cancer[J]. Cancer Res, 2001, 61(8): 3225-3229.
  • 4Suter CM, Norrie M, Ku SL, et al. CpG island methylation is a common finding in colorectal cancer cell lines[J]. Br J Cancer, 2003, 88(3): 413-419.
  • 5Sun L, Hui AM, Kanai Y, et al. Increased DNA methyltransferase expression is associated with an early stage of human hepatocarcinogenesis[J]. Jpn J Cancer Res, 1997, 88(12): 1165-1170.
  • 6Rhee I, Bachman KE, Park BH, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells[J]. Nature, 2002, 416(6880): 552-556.
  • 7Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands[J]. Proc Natl Sci USA, 1996, 93(18): 9821-9826.
  • 8Slack A, Cervoni N, Pinard M, et al. Feedback regulation of DNA methyltransferase gene expression by methylation[J]. Eur J Biochem, 1999, 264(1): 191-199.
  • 9Baylin SB, Herman JG, Graff JR, et al. Alterations in DNA methylation: a fundamental aspect of neoplasia[J]. Adv Cancer Res, 1998, 72: 141-196.
  • 10Clark SJ, Harrison J, Paul CL, et al. High sensitivity mapping of methylated cytosines[J]. Nucleic Acids Res, 1994, 22(15): 2990-2997.

二级参考文献15

  • 1Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet, 1999, 21: 163-167.
  • 2Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res, 1995, 55: 4525-4530.
  • 3Otterson GA, Khleif SN, Chen W, et al. CDNK2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-Aza-2′-deoxycytidine. Oncogene, 1995, 11: 1211-1216.
  • 4Sanchez-Cespedes M, Esteller M, Wu L, et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res, 2000, 60:892-895.
  • 5Heid CA, Stevens J, Livak KJ. Real time quantitative PCR. Genome Res, 1996, 6: 986-994.
  • 6Mizuno S, Chijiwa T, Okamura T, et al. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood, 2001, 97: 1172-1179.
  • 7Mancini DN, Rodenhiser DI, Ainsworth PJ, et al. CpG methylation within the 5′ regulatory region of BRCA1 gene is tumor specific and includes a putaitive CREB binding site. Oncogene, 1998, 16: 1161-1169.
  • 8Nan X, Ng HH, Johnson CA, et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 1998, 393: 386-389.
  • 9Bestar TH. Methylation meets acetylation. Nature, 1998, 393: 311-312.
  • 10Bird A. DNA methylation de novo. Science, 1999, 286: 2287-2288.

共引文献12

同被引文献33

  • 1杨祖立,汪建平,元云飞,蔡世荣,黄美近.结直肠癌侵袭性与脾酪氨酸激酶基因Syk启动子甲基化的关系[J].中华实验外科杂志,2005,22(1):68-70. 被引量:32
  • 2吕国丽,文剑明,张萌,胥健敏,徐若冰,董愉.5Aza-dc对癌细胞TIMP-3启动子去甲基化的作用[J].中国病理生理杂志,2005,21(9):1763-1768. 被引量:3
  • 3黄美近,汪建平,褚忠华,宋新明,王磊,杨祖立,蔡世荣.TIMP-3基因甲基化与结直肠癌临床病理的关系[J].中国病理生理杂志,2005,21(12):2418-2421. 被引量:2
  • 4Lee MP, Reeves C, Schmitt A, et al. Somatic mutation of TSSCS, a novel imprinted gene from human chromosome 11p15.5[J]. Cancer Res, 1998, 58(18) :4155 -4159.
  • 5Schwienhacher C, Gramantieri L, Scelfo R, et al. Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas [ J ]. Proc Natl Acad Sci USA, 2000, 97(10) :5445-5449.
  • 6Lee M, Sup HanW, Kyoung Kim O, et al. Prognostic value of p16iNK4a and p14ABF gene hypermethylation in human colon cancer[J]. Pathol Bes Pract, 2006, 202 (6) :415 -424.
  • 7Sharma D, Blum J, Yang X, et al. Release of methl CpG binding proteins and histone deaeetylasel from the estrogen receptor α (ER) promoter upon reactivation in ER - negative human breast cancer cells [J]. Mol Endocrinol, 2005, 19(7) :1740 - 1751.
  • 8Rand E, Cedar H. Regulation of imprinting: A multi - tiered process [J]. J Cell Biochem, 2003, 88(2) :400 - 407.
  • 9Gao ZH, Suppola S, Liu J, et al. Association of H19 prorooter methylation with the expression of H19 and IGF -Ⅱ genes in adrenocortical tumors [ J ]. J Clin Endocrinol Metab, 2002, 87(3) :1170 - 1176.
  • 10Hisatomi H, Nagac K, Wakita K, et al. ARHI/NOEY2 inactivation may be important in breast tumor pathogenesis [J]. Oncology,2002, 62(2) :136 - 140.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部